Author: Bereczki, Ilona; Csávás, Magdolna; Szűcs, Zsolt; Rőth, Erzsébet; Batta, Gyula; Ostorházi, Eszter; Naesens, Lieve; Borbás, Anikó; Herczegh, Pál
Title: Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin Cord-id: gf4iurr6 Document date: 2020_7_30
ID: gf4iurr6
Snippet: The limited scope of antiviral drugs and increasing problem of antiviral drug resistance represent a global health threat. Glycopeptide antibiotics and their lipophilic derivatives have emerged as relevant inhibitors of diverse viruses. Herein, we describe a new strategy for the synthesis of dual hydrophobic and lipophobic derivatives of glycopeptides to produce selective antiviral agents without membraneâ€disrupting activity. Perfluorobutyl and perfluorooctyl moieties were attached through lin
Document: The limited scope of antiviral drugs and increasing problem of antiviral drug resistance represent a global health threat. Glycopeptide antibiotics and their lipophilic derivatives have emerged as relevant inhibitors of diverse viruses. Herein, we describe a new strategy for the synthesis of dual hydrophobic and lipophobic derivatives of glycopeptides to produce selective antiviral agents without membraneâ€disrupting activity. Perfluorobutyl and perfluorooctyl moieties were attached through linkers of different length to azido derivatives of vancomycin aglycone and teicoplanin pseudoaglycone, and the new derivatives were evaluated against a diverse panel of viruses. The teicoplanin derivatives displayed strong antiâ€influenza virus activity at nontoxic concentrations. Some of the perfluoroalkylated glycopeptides were also active against a few other viruses such as herpes simplex virus or coronavirus. These data encourage further exploration of glycopeptide analogues for broad antiviral application.
Search related documents:
Co phrase search for related documents- activity cytotoxicity and low cytotoxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- activity cytotoxicity and low efficacy: 1, 2, 3
- acute sars cov respiratory syndrome coronavirus and low cytotoxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute sars cov respiratory syndrome coronavirus and low efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
Co phrase search for related documents, hyperlinks ordered by date